#Germline#genetictesting (GGT) in >7,000 consecutive #patients w/ #lungcancer
>14% had PGVs, 63% in DDR genes e.g. #BRCA1 #BRCA2 #ATM #CHEK2, 95% clinically actionable
"The results from this study and previous reports suggest it is reasonable for clinicians to now consider GGT for all #patients diagnosed w/ #LungCancer"
https://t.co/agmaZ2vNVQ @JCOPO_ASCO@ASCO @Invitae
#universal #germlinetesting #access #reducedisparities #precisionmedicine #precisiontherapy #clinicaltrials #precisionprevention #LCSM #LCAM #lungcancerawarenessmonth
Our latest findings from the @DCMProject recently published: Despite a higher estimated risk for familial DCM, detection of clinically actionable variants remains markedly lower in DCM patients of African Ancestry.
There are many Loc(k)i variations in UAB 1st years!
Please LIKE this tweet to vote for the UAB GCTP to win and retweet to help us get more likes @UABGCTP#Hallogene23#genechat@ASGCGP
Bryson Katona presenting data showing increased risk for gastric cancer in BRCA2 & ATM (and possibly BRCA1 & PALB2). Suggests H. pylori testing at dx (& treatment if +), endoscopic surveillance when undergoing EUS for pancreatic screening & if any upper GI symptoms. #CGAIGC23
Increasingly convinced that pharmacogenomics is important. 7% of people have a DPYD variant that causes an adverse reaction (including death) to 5-FU chemotherapy, yet it’s still not recommended in the US prior to 5-FU treatment. Great talk from Steve Offer at the US Oncology mtg
Our latest findings from the @DCMProject recently published: Despite a higher estimated risk for familial DCM, detection of clinically actionable variants remains markedly lower in DCM patients of African Ancestry.
We are excited to share our new publication from @emmakblanche et al “Genetic counsellors' research dissemination practices and attitudes”. You can read the full article here: https://t.co/7YamB47V1R [⅙]
Given the availability of an increasing number of gene therapies, there is a need to better define the role of medical geneticists within this new treatment paradigm.
Read how medical geneticists can contribute to effective gene therapy implementation: https://t.co/PdXS1itzJd
Are we ready for #genomic newborn screening?
👶🧬🌏 #RareDisease
As multiple large studies launch internationally, @Rich_Genomics and I review the evidence and gaps that now need to be addressed to inform policy
📣Out now in @NatureRevGenet
👉https://t.co/DXjrT5wh4l 🧵
📢As #PrideMonth draws to a close we are grateful for all of our LGBTQI+ pts & the dedicated professionals who help care for them.
➡️@spaulliver from @UChicago provides an excellent tutorial on care & communication for LGBTQI+ pts that can be seen here👉🔗https://t.co/38hKYtUEIi
Dr. Vinod Balachandran provides the latest data on the mRNA pancreatic cancer vaccine, now headed to a phase II clinical trial. https://t.co/YEVrjRjysh